Samaya vs. Glaucoma: How Our Minimally Invasive Surgery Works

published on: 12th october, 2025

Samaya vs. Glaucoma: How Our Minimally Invasive Surgery Works

Glaucoma has long been one of ophthalmology's most challenging conditions Glaucoma is also the First cause of irreversible blindness worldwide, this progressive eye disease affects millions globally, with particularly high prevalence in the Middle East region. Traditionally, treatment options were limited to medications and conventional surgeries that, while effective, often carried significant risks and recovery challenges. However, the landscape of glaucoma management has been transformed by the advent of Minimally Invasive Glaucoma Surgery (MIGS)—innovative procedures that provide effective pressure reduction with substantially improved safety profiles and recovery experiences. At Samaya Specialized Center in Abu Dhabi, our glaucoma specialists have pioneered the implementation of these advanced surgical techniques, offering UAE patients access to world-class glaucoma care that preserves vision while minimizing surgical impact. This comprehensive guide explores how Samaya's approach to MIGS, including advanced shunt implant procedures, is changing outcomes for glaucoma patients across the Emirates.

Understanding Glaucoma: The Silent Thief of Sight

Before exploring surgical innovations, it's essential to understand the condition they address. Glaucoma represents a group of eye diseases characterized by progressive damage to the optic nerve, typically associated with elevated intraocular pressure (IOP). This damage leads to gradual vision loss sometimes, beginning with peripheral vision and potentially progressing to complete blindness if left untreated.

Dr. Yahya Ali Yahya Al Midwahi, Consultant Ophthalmologist, Chairman, and Co-Founder of Samaya Specialized Center, explains: "What makes glaucoma particularly dangerous is its insidious nature. The most common form—primary open-angle glaucoma—typically produces no symptoms until significant vision loss has occurred. By the time many patients notice visual changes, permanent damage has already taken place."

In the UAE, several factors contribute to glaucoma's significant impact:

· High Prevalence: Studies indicate that glaucoma affects approximately 4-5% of UAE residents over age 40, with rates increasing significantly with age. This prevalence is higher than global averages, particularly for certain types of glaucoma.

· Genetic Factors: Some populations in the Middle East have genetic predispositions to specific forms of glaucoma, including pseudoexfoliation glaucoma and angle-closure glaucoma.

· Late Diagnosis: Due to its asymptomatic nature in early stages, many cases in the UAE are diagnosed only after significant damage has occurred. Studies suggest that up to 50% of glaucoma cases in the region remain undiagnosed.

· Environmental Factors: The UAE's climate and lifestyle factors, including high UV exposure and prevalence of diabetes, may contribute to glaucoma risk and progression.

The fundamental problem in most forms of glaucoma involves impaired drainage of aqueous humor—the clear fluid that fills the front portion of the eye. This fluid is continuously produced and normally drains through a mesh-like channel called the trabecular meshwork. When this drainage system doesn't function properly, fluid builds up, increasing pressure within the eye and damaging the optic nerve.

Traditional treatment approaches follow a stepwise progression:

1. Medication: Eye drops that either reduce fluid production or improve drainage
2. Laser Treatments: Procedures like Selective Laser Trabeculoplasty (SLT) that improve fluid outflow
3. Conventional Surgery: Procedures like trabeculectomy that create new drainage channels

While effective at lowering pressure, conventional glaucoma surgeries carry significant risks, including infection, bleeding, vision loss, and hypotony (pressure that's too low). Recovery can be lengthy, often requiring weeks of restricted activity and multiple follow-up visits. These limitations led to the development of MIGS—procedures designed to provide effective pressure reduction with substantially improved safety profiles.

The MIGS Revolution: Transforming Glaucoma Surgery

Minimally Invasive Glaucoma Surgery represents one of the most significant advances in glaucoma treatment over the past decade. These procedures utilize microscopic-scale instruments and devices to enhance aqueous outflow while minimizing trauma to ocular tissues.

Dr. Ameen Saleh Ali Al-Saleem, Consultant Ophthalmologist and Vice-Chairman and Founder of Samaya Specialized Center, describes the paradigm shift: "MIGS has fundamentally changed our approach to surgical glaucoma management. Rather than reserving surgery as a last resort due to its risks, we can now offer surgical intervention earlier in the disease process, often preventing the progression that might otherwise occur during years of medication management."

The MIGS category encompasses several different approaches, each with specific advantages for particular patient profiles:

· Trabecular Meshwork Bypass Devices: These tiny implants create a direct channel through the trabecular meshwork, allowing aqueous humor to flow directly into Schlemm's canal (the eye's natural drainage channel).

· Schlemm's Canal Dilation Procedures: These techniques enlarge the eye's natural drainage channel to improve outflow capacity.

· Suprachoroidal Shunts: These devices create a pathway for fluid to flow from the anterior chamber to the suprachoroidal space, utilizing a different drainage route.

· Subconjunctival Filtration: These procedures create a controlled outflow pathway to the space under the conjunctiva (the clear membrane covering the white of the eye).

At Samaya Specialized Center, the full spectrum of MIGS options is available, with procedures selected based on each patient's specific glaucoma type, severity, anatomy, and other factors. This personalized approach ensures optimal outcomes by matching the right procedure to each individual case.

The advantages of MIGS compared to traditional glaucoma surgery include:

· Enhanced Safety Profile: Complication rates are significantly lower than with traditional filtering surgeries like trabeculectomy.

· Faster Recovery: Most patients resume normal activities within days rather than weeks.

· Conjunctival Preservation: Many MIGS procedures spare the conjunctiva, preserving this tissue for possible future interventions if needed.

· Reduced Dependence on Medications: While not always eliminating the need for glaucoma medications, MIGS often reduces the number of medications required, improving quality of life and medication adherence.

· Combinability with Cataract Surgery: Many MIGS procedures can be performed simultaneously with cataract surgery, addressing both conditions with a single intervention.

Dr. Noura Almansoori, Consultant Ophthalmologist and Medical Director at Samaya, emphasizes the importance of this last point: "The ability to combine MIGS with cataract surgery represents a significant advantage for many patients. Since both glaucoma and cataracts are common age-related conditions, this combination approach provides comprehensive eye care with a single recovery period."

Shunt Implants: Advanced Solutions for Moderate to Advanced Glaucoma

Among the various MIGS options, shunt implant procedures represent a particularly important advancement for patients with moderate to advanced glaucoma or those who haven't achieved adequate pressure control with other interventions. Samaya Specialized Center has been at the forefront of implementing these technologies in the UAE.

Dr. Saleh Saif Al Messabi, Consultant Ophthalmologist and President of the Emirates Society of Ophthalmology who practices at Samaya, explains: "Glaucoma shunts create alternative pathways for aqueous humor to exit the eye, bypassing the damaged natural drainage system. The latest generation of these devices combines excellent efficacy with significantly improved safety profiles compared to earlier drainage implants."

Several types of shunt implants are utilized at Samaya, each with specific advantages for particular clinical scenarios:

· Gel Stent Microshunts: These devices, approximately the size of an eyelash, create a controlled pathway from the anterior chamber to the subconjunctival space. Made of a highly biocompatible gelatin material, they provide predictable pressure reduction with minimal tissue reaction.

· Trabecular Micro-Bypass Shunts: These tiny devices, often no larger than the date on a penny, are implanted directly into the trabecular meshwork to create a bypass channel into Schlemm's canal. They work with the eye's natural drainage system rather than creating an entirely new pathway.

· Suprachoroidal Microstents: These specialized shunts utilize the eye's uveoscleral pathway, directing fluid to the suprachoroidal space where it can be absorbed by the body. This approach often provides substantial pressure reduction while minimizing hypotony risk.

· Valved Tube Shunts: For more advanced cases, these devices incorporate flow-restricting valves that prevent excessive drainage, reducing the risk of hypotony while still providing robust pressure reduction.

· The shunt implantation procedure at Samaya typically follows this process:

· Preoperative Assessment: Comprehensive evaluation including detailed imaging of the drainage angles and outflow pathways to determine the optimal device and implantation approach.

· Surgical Planning: Customized surgical planning based on the patient's specific anatomy, glaucoma type, and pressure target.

· Minimally Invasive Implantation: The procedure is typically performed under local anesthesia with sedation. A microscopic incision provides access for precise device placement using specialized microsurgical instruments.

· Intraoperative Adjustments: Real-time pressure monitoring allows surgeons to confirm proper device function and make any necessary adjustments during the procedure.

· Wound Closure: The minimal incisions may be closed with few sutures or may be self-sealing, depending on the specific approach.

The entire procedure typically takes 25-40 minutes when performed as a standalone operation, or slightly longer when combined with cataract surgery. All patients go home the same day and experience minimal discomfort during recovery.

Dr. Mohammed Ali Eissa El Deeb, Consultant Ophthalmologist at Samaya, notes the dramatic difference in patient experience compared to traditional glaucoma surgery: "With conventional filtering procedures, patients often experienced significant postoperative discomfort, required multiple suture removals, and faced activity restrictions for weeks. With modern shunt implants, most patients report minimal discomfort, require fewer postoperative visits, and return to normal activities within days."

The Procedure: Inside Samaya's Approach to MIGS

The success of MIGS procedures depends not only on the devices themselves but on the expertise with which they're implanted. Samaya Specialized Center has developed comprehensive protocols for these procedures, incorporating international best practices with refinements based on the center's extensive experience.

· Preoperative Preparation

· The journey begins with thorough preparation:

· Comprehensive Evaluation: Beyond standard glaucoma assessments, patients undergo advanced imaging including anterior segment OCT, ultrasound biomicroscopy, and specialized angle visualization to identify the optimal MIGS approach.

· Medication Optimization: Certain medications may be adjusted before surgery to reduce bleeding risk and optimize surgical conditions.

· Infection Prevention: Prophylactic measures including antiseptic lid scrubs and antibiotic drops begin before surgery to minimize infection risk.

· Anesthesia Planning: Most procedures are performed under local anesthesia with mild sedation, though options are tailored to each patient's needs and preferences.

· Day of Surgery

· The surgical experience at Samaya emphasizes both technical excellence and patient comfort:

· Surgical Environment: Procedures are performed in specialized ophthalmic operating theaters with advanced microscopy systems and precise surgical instruments.

· Anesthesia Administration: Most patients receive only local anesthesia and mild sedation, allowing for quick recovery while ensuring comfort during the procedure.

· Surgical Technique: The surgeon creates microscopic incisions (often less than 2mm) to access the target implantation site. Using high-magnification visualization, the selected device is precisely positioned to create the optimal drainage pathway.

· Intraoperative Testing: Many procedures include real-time testing of device function, with adjustments made as needed to achieve the desired flow characteristics.

· Wound Closure: The minimal incisions often require no sutures or only a single dissolvable suture, contributing to faster healing and reduced postoperative discomfort.

Dr. Tariq Yasin Al-Rawashdeh, Consultant Ophthalmologist and Vitreoretinal Surgeon at Samaya, emphasizes the importance of surgical precision: "The difference between good and excellent outcomes often comes down to submillimeter precision in device placement. Our advanced visualization systems and specialized instruments allow for this level of precision, which directly translates to better pressure control and fewer complications."

Recovery Process

The recovery experience represents one of the most significant advantages of MIGS compared to traditional glaucoma surgery:

Immediate Postoperative Period (First 24 Hours)

• Mild discomfort typically managed with over-the-counter pain relievers
• Slight blurring of vision, which gradually improves
• Some redness and minor swelling around the eye
• Eye protection (shield or glasses) worn when sleeping
• Prescribed eye drops used according to schedule
• Avoidance of strenuous activity, heavy lifting, or bending over

Dr. Matta Mansour, Consultant Anesthesiologist and Deputy Medical Director at Samaya, notes: "Most patients are pleasantly surprised by how comfortable they are immediately after surgery. The minimal tissue disruption with MIGS procedures translates to significantly less inflammation and discomfort compared to traditional glaucoma surgery."

Days 2-7

• Discomfort typically resolves completely within 2-3 days
• Vision begins stabilizing, though some fluctuation is normal
• Eye drops continued according to prescribed schedule
• Light activities resumed, including reading, television, and computer use
• Driving usually permitted after 2-3 days, once vision stabilizes
• Showering allowed, but avoiding water directly in the eye
• Follow-up visit typically scheduled within this period to monitor healing

Weeks 2-4

• Most patients have resumed all normal activities
• Vision continues improving as healing progresses
• Eye drop regimen may begin tapering, depending on pressure readings
• Light exercise usually permitted after 2 weeks
• Swimming and more strenuous activities typically allowed after 3-4 weeks
• Second follow-up visit to assess pressure control and device function

Months 1-3

• Long-term pressure control becomes apparent
• Medication regimen finalized based on surgical outcome
• Any minor visual fluctuations typically resolve
• All normal activities resumed without restrictions
• Follow-up visits become less frequent as stability is confirmed

Dr. Abdalla Taha Mohamed Elmobark, General Practitioner at Samaya, emphasizes the importance of the postoperative care regimen: "While the surgery itself is critical, following the postoperative care instructions is equally important for optimal outcomes. The eye drop regimen, activity guidelines, and follow-up schedule are all carefully designed to promote healing and ensure the best possible pressure control."

Comparing Options: MIGS vs. Traditional Glaucoma Surgery

To help patients understand their surgical options, Samaya Specialized Center provides clear comparisons between MIGS procedures and traditional glaucoma surgeries. This information helps patients make informed decisions about their treatment path.

Efficacy Comparison

• Traditional Surgery (Trabeculectomy): Typically achieves 50-60% pressure reduction; often can eliminate medication need completely
• MIGS Procedures: Generally achieves 30-45% pressure reduction; often reduces but may not eliminate all medications
• Advanced Shunt Implants: Can achieve 40-50% pressure reduction; bridges the gap between traditional surgery and less invasive MIGS

Safety Profile Comparison

• Traditional Surgery: Higher complication rates (10-15% risk of serious complications); includes risks of infection, bleeding, cataract formation, hypotony, and vision loss
• MIGS Procedures: Significantly lower complication rates (1-5% risk of serious complications); reduced risk of hypotony and vision-threatening complications
• Advanced Shunt Implants: Moderate complication rates (3-7% risk of serious complications); improved safety profile compared to traditional surgery while providing robust efficacy

Recovery Comparison

• Traditional Surgery: Extended recovery (4-6 weeks before resuming normal activities); multiple postoperative visits; suture removal often required; activity restrictions significant
• MIGS Procedures: Rapid recovery (most activities resumed within 1 week); fewer postoperative visits; typically no suture removal; minimal activity restrictions
• Advanced Shunt Implants: Moderate recovery (most activities resumed within 2 weeks); balanced postoperative regimen; limited activity restrictions

Longevity Comparison

• Traditional Surgery: Generally provides long-term pressure control (10+ years in successful cases)
• MIGS Procedures: Emerging long-term data; most show sustained effectiveness for 5+ years
• Advanced Shunt Implants: Growing evidence for long-term efficacy (7+ years in most cases)

Dr. Noura Almansoori summarizes the comparison: "Traditional filtering surgery still has an important place for certain patients, particularly those with advanced or aggressive glaucoma requiring maximal pressure reduction. However, for many patients, MIGS procedures offer an excellent balance of efficacy and safety, with quality-of-life advantages during recovery that shouldn't be underestimated."

Beyond Surgery: Samaya's Comprehensive Glaucoma Management

While surgical innovations represent a significant advancement in glaucoma care, Samaya Specialized Center emphasizes that optimal outcomes require a comprehensive management approach. Surgery is just one component of the center's multifaceted glaucoma program.

Advanced Diagnostics

Early detection and precise monitoring are critical for preserving vision in glaucoma patients. Samaya utilizes state-of-the-art diagnostic technologies including:

· Optical Coherence Tomography (OCT): Provides detailed imaging of the optic nerve and retinal nerve fiber layer, allowing detection of damage before visual field loss occurs.

· Visual Field Testing: Advanced perimetry systems assess peripheral vision with greater sensitivity than traditional methods.

· Corneal Pachymetry: Measures corneal thickness, an important factor in interpreting pressure readings and assessing glaucoma risk.

· 24-Hour Pressure Monitoring: Specialized contact lens sensors can track pressure fluctuations throughout the day and night, providing insights not available from single office measurements.

· Anterior Segment Imaging: Advanced technologies visualize the eye's drainage structures, helping identify the most appropriate surgical approach.

Dr. Ameen Saleh Ali Al-Saleem notes: "The diagnostic capabilities available today allow us to detect glaucoma earlier and monitor progression with unprecedented precision. This translates directly to better outcomes, as we can intervene before significant vision loss occurs."

Medication Management

For many patients, medications remain an important component of glaucoma management, either as primary therapy or as an adjunct to surgical intervention. Samaya's approach includes:

· Personalized Medication Selection: Choosing agents based on individual factors including pressure target, side effect profiles, and lifestyle factors.

· Adherence Support: Utilizing technologies and strategies to improve medication compliance, including reminder systems, simplified regimens, and education about proper administration techniques.

· Minimizing Side Effects: Proactively addressing medication side effects through formulation changes, preservative-free options, and adjunctive therapies for ocular surface disease.

· Regular Medication Reviews: Periodically reassessing medication regimens to ensure continued effectiveness and appropriateness.

· Lifestyle Modifications

· Emerging evidence suggests that certain lifestyle factors may influence glaucoma progression. Samaya provides guidance on:

· Exercise Considerations: Regular moderate exercise appears beneficial for most glaucoma patients, though certain high-intensity activities may temporarily increase eye pressure.

· Dietary Factors: Some evidence suggests that diets rich in antioxidants and omega-3 fatty acids may be beneficial for optic nerve health.

· Sleep Position: For some patients, elevated head position during sleep may help reduce nocturnal pressure spikes.

· Stress Management: Chronic stress may influence intraocular pressure in some individuals; stress reduction techniques may provide modest benefits.

· Smoking Cessation: Smoking appears to increase glaucoma risk and may accelerate progression; cessation support is provided when needed.

Dr. Yahya Al Midwahi emphasizes the holistic approach: "While surgical and medical interventions are the cornerstones of glaucoma management, we recognize that many factors influence long-term outcomes. Our comprehensive approach addresses all aspects of the patient's health that may impact their glaucoma course."

The Future of Glaucoma Surgery at Samaya

As a leader in ophthalmic innovation in the UAE, Samaya Specialized Center continues to advance glaucoma surgical care through several initiatives:

· Emerging Technologies

· The center is actively evaluating and implementing next-generation glaucoma devices and techniques:

· Sustained-Release Drug Delivery Implants: Devices that can deliver glaucoma medication continuously for months or years, eliminating the need for daily drops.

· Adjustable Shunt Technologies: Newer devices that allow for non-invasive adjustment of flow characteristics after implantation, providing customized pressure control without additional surgery.

· Minimally Invasive Angle-Based Procedures: Emerging techniques that address the primary site of outflow resistance with even less tissue disruption than current MIGS approaches.

· Neuroprotection Strategies: Complementary approaches focused on protecting the optic nerve independent of pressure control, potentially preserving vision even in cases where pressure control is challenging.

· Research Participation

· Samaya participates in international clinical trials evaluating new glaucoma technologies, providing UAE patients with access to innovative treatments before they become widely available:

· Device Trials: Evaluating next-generation MIGS devices and comparing outcomes between different approaches.

· Combination Therapy Studies: Investigating optimal combinations of surgical, laser, and medical therapies for different glaucoma types and severities.

· Long-Term Outcomes Research: Contributing to the growing body of evidence regarding the durability and effectiveness of MIGS procedures over extended periods.

· Quality of Life Studies: Assessing how different treatment approaches impact patients' daily functioning and satisfaction beyond simple pressure measurements.

Dr. Saleh Saif Al Messabi notes: "By participating in international research, we not only provide our patients with early access to promising technologies but also contribute to the global advancement of glaucoma care. The data we generate helps refine surgical techniques and device designs for future patients worldwide."

Training and Education

As early adopters of MIGS technologies in the region, Samaya's specialists play an important role in educating the broader ophthalmic community:

· Surgical Training Programs: Providing hands-on training for ophthalmologists from throughout the Middle East on advanced MIGS techniques.

· Observership Opportunities: Hosting visiting surgeons who wish to observe MIGS procedures before implementing them in their own practices.

· Conference Presentations: Sharing outcomes data and surgical pearls at regional and international ophthalmology conferences.

· Patient Education Initiatives: Developing resources to help patients understand their glaucoma and the treatment options available to them.

Dr. Mohammed Ali Eissa El Deeb emphasizes the importance of these educational efforts: "As these technologies become more widely available, ensuring that surgeons are properly trained in their use is critical for patient safety and optimal outcomes. Our center is committed to sharing our expertise to elevate the standard of glaucoma care throughout the region."

A New Era in Glaucoma Management

The evolution of glaucoma surgery represents one of the most significant advances in ophthalmology over the past decade. For patients facing this potentially blinding condition, minimally invasive approaches offer new hope—effective pressure control with dramatically improved safety profiles and recovery experiences.

At Samaya Specialized Center, the comprehensive approach to glaucoma management combines these surgical innovations with advanced diagnostics, optimized medical therapy, and personalized care plans. This multifaceted strategy addresses not just the pressure elevation characteristic of glaucoma but the overall goal of preserving vision and quality of life throughout the patient's lifetime.

For UAE residents affected by glaucoma, the message is clear: modern management options offer better outcomes with less disruption to daily life than ever before. Early detection remains crucial, as intervention before significant damage occurs provides the best chance for preserving vision. However, even for those with more advanced disease, new surgical approaches offer effective options with improved safety profiles.

As Dr. Ameen Saleh Ali Al-Saleem concludes: "We've entered a new era in glaucoma management where surgery is no longer the last resort but often an early intervention that can change the disease trajectory. At Samaya, we're proud to offer these advanced options and to continue advancing the field through our clinical work, research participation, and educational efforts."

Share to Support Glaucoma Awareness

Help us spread awareness about modern glaucoma treatment options. Share this article on social media to help others understand that glaucoma can be effectively managed with today's advanced surgical techniques. Early detection and treatment are key to preserving vision—your share could help someone take the first step toward protecting their sight.